These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9395126)

  • 21. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.
    Rauchhaus M; Koloczek V; Volk H; Kemp M; Niebauer J; Francis DP; Coats AJ; Anker SD
    Int J Cardiol; 2000; 76(2-3):125-33. PubMed ID: 11104867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TACE mRNA expression in peripheral mononudear cells precedes new lesions on MRI in multiple sclerosis.
    Seifert T; Kieseier BC; Ropele S; Strasser-Fuchs S; Quehenberger F; Fazekas F; Hartung HP
    Mult Scler; 2002 Dec; 8(6):447-51. PubMed ID: 12474981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses.
    Bertolotto A; Malucchi S; Capobianco M; Manzardo E; Guastamacchia G; Milano E; Audano L; Mutani R
    J Interferon Cytokine Res; 1999 Jun; 19(6):575-81. PubMed ID: 10433357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
    Wipfler P; Heikkinen A; Harrer A; Pilz G; Kunz A; Golaszewski SM; Reuss R; Oschmann P; Kraus J
    J Neurol; 2013 Jan; 260(1):221-7. PubMed ID: 22875099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis.
    van Boxel-Dezaire AH; Hoff SC; van Oosten BW; Verweij CL; Dräger AM; Adèr HJ; van Houwelingen JC; Barkhof F; Polman CH; Nagelkerken L
    Ann Neurol; 1999 Jun; 45(6):695-703. PubMed ID: 10360761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNF-α and its receptors modulate complex behaviours and neurotrophins in transgenic mice.
    Camara ML; Corrigan F; Jaehne EJ; Jawahar MC; Anscomb H; Koerner H; Baune BT
    Psychoneuroendocrinology; 2013 Dec; 38(12):3102-14. PubMed ID: 24094876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS.
    Huang W-X ; Huang MP; Gomes MA; Hillert J
    Neurology; 2000 Oct; 55(7):928-34. PubMed ID: 11061246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of tumor necrosis factor receptors 1 and 2 of the goldfish (Carassius aurutus L.).
    Grayfer L; Belosevic M
    Mol Immunol; 2009 Jul; 46(11-12):2190-9. PubMed ID: 19446337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble fractions of tumor necrosis factor-alpha, interleukin-6 and of their receptors in toxic epidermal necrolysis: a comparison with second-degree burns.
    Paquet P; Piérard GE
    Int J Mol Med; 1998 Feb; 1(2):459-62. PubMed ID: 9852250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
    Tran TA; Kallakury BV; Ambros RA; Ross JS
    Cancer; 1998 Jul; 83(2):276-82. PubMed ID: 9669810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRAIL-receptor expression is an independent prognostic factor for survival in patients with a primary glioblastoma multiforme.
    Kuijlen JM; Mooij JJ; Platteel I; Hoving EW; van der Graaf WT; Span MM; Hollema H; den Dunnen WF
    J Neurooncol; 2006 Jun; 78(2):161-71. PubMed ID: 16544055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [TNF-alpha and soluble TNF receptor p55 in patients wtih multiple sclerosis].
    Geppert A; Losy J
    Neurol Neurochir Pol; 1999; 33(4):807-14. PubMed ID: 10612095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.
    Braun N; Michel U; Ernst BP; Metzner R; Bitsch A; Weber F; Rieckmann P
    Neurosci Lett; 1996 Sep; 215(2):75-8. PubMed ID: 8887999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy.
    Tawdy MH; Abd El Nasser MM; Abd El Shafy SS; Nada MA; El Sirafy MN; Magd AH
    J Clin Neurosci; 2014 Sep; 21(9):1606-11. PubMed ID: 24913933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.
    Sarchielli P; Critelli A; Greco L; Sokola E; Floridi A; Gallai V
    Cytokine; 2001 Jun; 14(5):294-8. PubMed ID: 11444910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Levels of Biomarkers of Immune Activation and Associations With Neurological Impairment in Relapsing-Remitting Multiple Sclerosis Patients During Remission.
    Witkowska AM; Socha K; Kochanowicz J; Karpińska E; Jakoniuk M; Zujko ME; Wilkiel M; Borawska MH; Mariak Z
    Biol Res Nurs; 2016 Jan; 18(1):113-9. PubMed ID: 25911236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.